Thrivent Financial For Lutherans Crispr Therapeutics Ag Transaction History

Thrivent Financial For Lutherans

$52.6 Billion
Q3 2024

A detailed history of Thrivent Financial For Lutherans transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 47,696 shares of CRSP stock, worth $1.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

47,696

Previous 47,223 1.0%

Holding current value

$1.96 Million

Previous $2.55 Million 12.15%

% of portfolio

0.0%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$44.62 - $62.75 $21,105 - $29,680	473 Added 1.0%	47,696 $2.24 Million
Q2 2024 Aug 13, 2024	BUY	$51.17 - $68.18 $821,329 - $1.09 Million	16,051 Added 51.49%	47,223 $2.55 Million
Q1 2024 May 14, 2024	SELL	$60.67 - $89.12 $409,583 - $601,649	-6,751 Reduced 17.8%	31,172 $2.13 Million
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $159,770 - $298,608	4,137 Added 12.24%	37,923 $2.37 Million
Q3 2023 Nov 14, 2023	SELL	$45.39 - $59.0 $681,621 - $886,003	-15,017 Reduced 30.77%	33,786 $1.53 Million
Q2 2023 Aug 14, 2023	SELL	$43.47 - $67.77 $17,431 - $27,175	-401 Reduced 0.81%	48,803 $2.74 Million
Q1 2023 May 17, 2023	SELL	$41.0 - $56.12 $1.21 Million - $1.66 Million	-29,612 Reduced 37.57%	49,204 $2.23 Million
Q4 2022 Feb 08, 2023	BUY	$39.19 - $65.67 $2.1 Million - $3.52 Million	53,608 Added 212.66%	78,816 $3.2 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $253,198 - $347,184	4,144 Added 19.67%	25,208 $1.65 Million
Q2 2022 Aug 16, 2022	BUY	$43.23 - $73.83 $405,583 - $692,673	9,382 Added 80.31%	21,064 $1.28 Million
Q1 2022 May 13, 2022	SELL	$53.19 - $79.24 $1.53 Million - $2.27 Million	-28,702 Reduced 71.07%	11,682 $733,000
Q4 2021 Feb 16, 2022	BUY	$70.09 - $111.29 $2.7 Million - $4.29 Million	38,516 Added 2061.88%	40,384 $3.4 Million
Q3 2021 Nov 15, 2021	SELL	$110.2 - $156.64 $230,097 - $327,064	-2,088 Reduced 52.78%	1,868 $209,000
Q2 2021 Sep 24, 2021	BUY	$100.84 - $161.89 $266,217 - $427,389	2,640 Added 200.61%	3,956 $640,000
Q2 2021 Aug 19, 2021	SELL	$100.84 - $161.89 $127,764 - $205,114	-1,267 Reduced 49.05%	1,316 $213,000
Q1 2021 May 17, 2021	BUY	$110.72 - $210.04 $107,619 - $204,158	972 Added 60.34%	2,583 $315,000
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $128,348 - $279,073	1,611 New	1,611 $247,000

Others Institutions Holding CRSP

# of Institutions

490

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.2B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account

Thrivent Financial For Lutherans Crispr Therapeutics Ag Transaction History